By blocking the VEGF–VEGFR signaling pathway (on-target action) sunitinib reduces capillary density and inhibits the generation of nitric oxide (NO), thus blunting the vasodilation of NO and leading to hypertension and myocardial stress. Here, VEGFA is linked to hypertensive disorder.